Cedar Mountain Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3K Hold
90
﹤0.01% 313
2026
Q1
$18.1K Hold
90
﹤0.01% 322
2025
Q4
$18.6K Hold
90
﹤0.01% 191
2025
Q3
$16.2K Sell
90
-154
-63% -$26.2K ﹤0.01% 206
2025
Q2
$39.3K Hold
244
0.01% 113
2025
Q1
$41.5K Hold
244
0.01% 104
2024
Q4
$40.5K Buy
244
+2
+0.8% +$342 0.01% 101
2024
Q3
$41.6K Hold
242
0.01% 96
2024
Q2
$37.3K Hold
242
0.01% 90
2024
Q1
$37.2K Hold
242
0.01% 91
2023
Q4
$38.2K Hold
242
0.01% 85
2023
Q3
$35.4K Hold
242
0.01% 83
2023
Q2
$37.1K Hold
242
0.01% 87
2023
Q1
$37.5K Hold
242
0.01% 84
2022
Q4
$37.3K Hold
242
0.01% 86
2022
Q3
$32K Hold
242
0.01% 89
2022
Q2
$33K Hold
242
0.01% 90
2022
Q1
$36K Hold
242
0.01% 93
2021
Q4
$39K Hold
242
0.01% 88
2021
Q3
$40K Hold
242
0.01% 80
2021
Q2
$42K Hold
242
0.01% 77
2021
Q1
$39K Hold
242
0.01% 87
2020
Q4
$41K Hold
242
0.01% 79
2020
Q3
$38K Hold
242
0.02% 75
2020
Q2
$41K Sell
242
-16
-6% -$2.51K 0.02% 73
2020
Q1
$34K Hold
258
0.02% 68
2019
Q4
$38K Buy
+258
New +$35.4K 0.02% 78

Other funds holding FBT

Cedar Mountain Advisors's FBT Position: Q2 2026 in Review

Cedar Mountain Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 90 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Cedar Mountain Advisors first reported a position in FBT in Q4 2019 and has held it in 27 quarters since. The position peaked at $42K in Q2 2021. 53 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Cedar Mountain Advisors held 90 shares of First Trust NYSE Arca Biotechnology Index Fund worth $22.3K as of Q2 2026.
  • Cedar Mountain Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #313 holding.
  • Cedar Mountain Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 27 quarters since.
  • Cedar Mountain Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $42K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.